Clinical experience with ceftazidime/avibactam in patients with severe infections, including meningitis and lung abscesses, caused by extensively drug-resistant Pseudomonas aeruginosa

被引：33
|
作者：
Xipell, Marc [1 ]
Bodro, Marta [1 ]
Marco, Francesc [2 ]
Losno, Ricardo A. [1 ]
Cardozo, Celia [1 ]
Soriano, Alex [1 ]
机构：
[1] Univ Barcelona, Hosp Clin IDIBAPS, Dept Infect Dis, Villarroel 170, E-08036 Barcelona, Spain
[2] Univ Barcelona, Hosp Clin ISGLOBAL, Dept Microbiol, Barcelona, Spain
来源：
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2017年 / 49卷 / 02期
关键词：
AVIBACTAM; MORTALITY;
D O I：
10.1016/j.ijantimicag.2016.11.005
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：266 / 268
页数：4
相关论文
共 50 条
  • [21] Extensively drug-resistant Pseudomonas aeruginosa: risk of bloodstream infection in hospitalized patients
    C. Peña
    S. Gómez-Zorrilla
    C. Suarez
    M. A. Dominguez
    F. Tubau
    O. Arch
    A. Oliver
    M. Pujol
    J. Ariza
    European Journal of Clinical Microbiology & Infectious Diseases, 2012, 31 : 2791 - 2797
  • [22] Impact of colistin plasma levels on the clinical outcome of patients with infections caused by extremely drug-resistant Pseudomonas aeruginosa
    Luisa Sorlí
    Sonia Luque
    Concepción Segura
    Nuria Campillo
    Milagro Montero
    Erika Esteve
    Sabina Herrera
    Natividad Benito
    Francisco Alvarez-Lerma
    Santiago Grau
    Juan Pablo Horcajada
    BMC Infectious Diseases, 17
  • [23] Extensively drug-resistant Pseudomonas aeruginosa: risk of bloodstream infection in hospitalized patients
    Pena, C.
    Gomez-Zorrilla, S.
    Suarez, C.
    Dominguez, M. A.
    Tubau, F.
    Arch, O.
    Oliver, A.
    Pujol, M.
    Ariza, J.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2012, 31 (10) : 2791 - 2797
  • [24] Impact of colistin plasma levels on the clinical outcome of patients with infections caused by extremely drug-resistant Pseudomonas aeruginosa
    Sorli, Luisa
    Luque, Sonia
    Segura, Concepcion
    Campillo, Nuria
    Montero, Milagro
    Esteve, Erika
    Herrera, Sabina
    Benito, Natividad
    Alvarez-Lerma, Francisco
    Grau, Santiago
    Pablo Horcajada, Juan
    BMC INFECTIOUS DISEASES, 2017, 17
  • [25] Use of ceftolozane/tazobactam as salvage therapy for infections due to extensively drug-resistant Pseudomonas aeruginosa
    Dinh, Aurelien
    Wyplosz, Benjamin
    Kerneis, Solen
    Lebeaux, David
    Bouchand, Frederique
    Duran, Clara
    Beraud, Guillaume
    Lazaro, Pauline
    Davido, Benjamin
    Henard, Sandrine
    Canoui, Etienne
    Ferry, Tristan
    Wolff, Michel
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 49 (06) : 782 - 783
  • [26] Emergence of KPC-31, a KPC-3 Variant Associated with Ceftazidime-Avibactam Resistance, in an Extensively Drug-Resistant ST235 Pseudomonas aeruginosa Clinical Isolate
    Faccone, Diego
    de Mendieta, Juan M.
    Albornoz, Ezequiel
    Chavez, Magali
    Genero, Fabiana
    Echegorry, Mariano
    Ceriana, Paola
    Mora, Andrea
    Seah, Christine
    Corso, Alejandra
    Melano, Roberto G.
    Pasteran, Fernando
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (11)
  • [27] Clinical efficacy of ceftazidime/avibactam combination therapy for severe hospital-acquired pulmonary infections caused by carbapenem-resistant and difficult-to-treat Pseudomonas aeruginosa
    Xu, Chenfeng
    Zeng, Fang
    Huang, Yifei
    Xu, Qiling
    Yang, Yu
    Gong, Weijing
    Shi, Chen
    Zhang, Yu
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2024, 63 (01)
  • [28] Tazobactam/ceftolozane and tobramycin combination therapy in extensively drug-resistant Pseudomonas aeruginosa infections in severe burn injury: a case report
    Yuta Ibe
    Ryuichiro Kakizaki
    Hirotoshi Inamura
    Tomoyuki Ishigo
    Yoshihiro Fujiya
    Hiroyuki Inoue
    Shuji Uemura
    Satoshi Fujii
    Satoshi Takahashi
    Eichi Narimatsu
    Masahide Fukudo
    Journal of Pharmaceutical Health Care and Sciences, 9
  • [29] Tazobactam/ceftolozane and tobramycin combination therapy in extensively drug-resistant Pseudomonas aeruginosa infections in severe burn injury: a case report
    Ibe, Yuta
    Kakizaki, Ryuichiro
    Inamura, Hirotoshi
    Ishigo, Tomoyuki
    Fujiya, Yoshihiro
    Inoue, Hiroyuki
    Uemura, Shuji
    Fujii, Satoshi
    Takahashi, Satoshi
    Narimatsu, Eichi
    Fukudo, Masahide
    JOURNAL OF PHARMACEUTICAL HEALTH CARE AND SCIENCES, 2023, 9 (01)
  • [30] Suboptimal Concentrations of Ceftazidime/Avibactam (CAZ-AVI) May Select for CAZ-AVI Resistance in Extensively Drug-Resistant Pseudomonas aeruginosa: In Vivo and In Vitro Evidence
    Lopez-Montesinos, Inmaculada
    Milagro Montero, Maria
    Domene-Ochoa, Sandra
    Lopez-Causape, Carla
    Echeverria, Daniel
    Sorli, Luisa
    Campillo, Nuria
    Luque, Sonia
    Padilla, Eduardo
    Prim, Nuria
    Grau, Santiago
    Oliver, Antonio
    Horcajada, Juan P.
    ANTIBIOTICS-BASEL, 2022, 11 (11):
12345